Released on = April 10, 2007, 9:56 am

Press Release Author = AnaSpec Inc.

Industry = Biotech

Press Release Summary = Continuing in its commitment to rapidly expand its antibody
offerings, AnaSpec, a leading provider of integrated proteomics solutions, added
fifty-one (51) new antibodies to its growing collection of catalog antibodies.

Press Release Body = AnaSpec Introduces 51 New Apoptosis-Related Antibodies

San Jose, CA - April 10, 2007

Continuing in its commitment to rapidly expand its antibody offerings, AnaSpec, a
leading provider of integrated proteomics solutions, added fifty-one (51) new
antibodies to its growing collection of catalog antibodies. The targeted
researchers area for these antibodies is apoptosis.


Anti-ADAM10 (CT) KUZ; MADM - Cat# 28071, 50 µg

Anti-Bax - Cat# 53252, 50 µg

Anti-Bcl-2 (pThr129) - Cat# 29658, 50 µg

Anti-Bcl-2alpha - Cat# 53256, 50 µg

Anti-Bcl-2alpha - Cat# 53257, 50 µg

Anti-Bcl-X - Cat# 53260, 50 µg

Anti-bcl-X - Cat# 53261, 50 µg

Anti-Bcl-xL - Cat# 53262, 50 µg

Anti-bcl-XL - Cat# 53263, 50 µg

Anti-Bim - Cat# 53265, 50 µg

Anti-BRCA1 - Cat# 53272, 50 µg

Anti-BRCA2 - Cat# 53273, 50 µg

Anti-Caspase-8L - Cat# 29625, 50 µg

Anti-MADD - Cat# 53623, 50 µg
MAP-kinase-Activating Death Domain protein

Anti-MAGE (IN) - Cat# 28004, 50 µg

Anti-Mammaglobin - Cat# 53625, 50 µg

Anti-Mcl-1 - Cat# 53628, 50 µg
Myeloid cell leukemia-1

Anti-MDM2 - Cat# 53631, 50 µg

Anti-MGMT - Cat# 53644, 50 µg
methylguanine-DNA methyltransferase

Anti-MLH1 - Cat# 53665, 50 µg

Anti-MMF-4/Myogenin - Cat# 53666, 50 µg

Anti-MMP-1 (COLLAGENASE-1) - Cat# 53667, 50 µg

Anti-MMP-1 (NT) - Cat# 29574, 50 µg
Collagenase-1; Interstitial Collagenase

Anti-MMP-10 (Stromilysin-2) - Cat# 53668, 50 µg
Matrix MetalloProteinases-10

Anti-MMP-11 (Stromelysin-3) - Cat# 53669, 50 µg

Anti-MMP-13 (Collagenase-3) - Cat# 53670, 50 µg

Anti-MMP-14 - Cat# 53671, 50 µg

Anti-MMP-15 - Cat# 53672, 50 µg

Anti-MMP-19 - Cat# 53673, 50 µg

Anti-MMP-2 - Cat# 29575, 50 µg
Gelatinase A

Anti-MMP-2 (72 kDa Collagenase IV) - Cat# 53674, 50 µg

Anti-MMP-23 - Cat# 53675, 50 µg

Anti-MMP-3 (NT) - Cat# 29576, 50 µg
Stromelysin-1

Anti-MMP-3 (Stromelysin-1) - Cat# 53676, 50 µg

Anti-MMP-7 (Matrilysin) - Cat# 53677, 50 µg

Anti-MMP8 (hinge) - Cat# 29578, 50 µg
Collagenase 2; Neutrophil Collagenase

Anti-p14ARF - Cat# 53733, 50 µg

Anti-p16INK4a - Cat# 53735, 50 µg

Anti-p27Kip1 - Cat# 53744, 50 µg

Anti-p504S/ AMACR - Cat# 53747, 50 µg

Anti-p57Kip2 - Cat# 53752, 50 µg

Anti-p63 - Cat# 53753, 50 µg

Anti-PARP - Cat# 53761, 50 µg

Anti-Prohibitin - Cat# 53796, 50 µg

Anti-Prostate Apoptosis Response Protein-4 - Cat# 53800, 50 µg

Anti-PTEN (pSer385) - Cat# 29642, 50 µg

Anti-Retinoblastoma - Cat# 53823, 50 µg

Anti-TGase II - Cat# 53892, 50 µg

Anti-TRADD - Cat# 53921, 50 µg

Anti-Ube1L - Cat# 53933, 50 µg

Anti-von Hippel-Lindau Protein - Cat# 53948, 50 µg

For more information visit www.anaspec.com

Company Info
AnaSpec, Inc. is a leading provider of integrated proteomics solutions to
pharmaceutical, biotech, and academic research institutions throughout the world.
With a vision for innovation through synergy, AnaSpec focuses on three core
technologies: peptides, detection reagents, and combinatorial chemistry.
Established in 1993, AnaSpec\'s headquarters and manufacturing facilities are located
in San Jose, CA.


Web Site = http://www.anaspec.com

Contact Details = 2149 O\'toole Ave.
San Jose, CA 95131
1-408-452-5055
ping@anaspec.com